Ascentage Pharma Group International SEC filings AAPG
Ascentage Pharma Group International has 132 filings in SEC EDGAR's recent list, going back to Jun 14, 2024. Its latest annual report, Form 20-F, was filed on Apr 29, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Oct 28, 2026. The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 3 | Initial insider ownership | Jun 29, 2026 | Jun 25, 2026 |
| 4 | Insider transaction | May 22, 2026 | May 20, 2026 |
| 4 | Insider transaction | May 22, 2026 | May 20, 2026 |
| 4 | Insider transaction | Apr 21, 2026 | Apr 20, 2026 |
| 3 | Initial insider ownership | Apr 21, 2026 | Mar 18, 2026 |
| 3/A | Primary document | Apr 20, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Apr 10, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 23, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 23, 2026 | Mar 18, 2026 |
| 3/A | Primary document | Mar 23, 2026 | Mar 18, 2026 |
| 3/A | Primary document | Mar 23, 2026 | Mar 18, 2026 |
| 3/A | Primary document | Mar 23, 2026 | Mar 18, 2026 |
| 3/A | Primary document | Mar 23, 2026 | Mar 18, 2026 |
| 3/A | Primary document | Mar 23, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 23, 2026 | Mar 18, 2026 |
| 3/A | Primary document | Mar 23, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 23, 2026 | Mar 18, 2026 |
| 3/A | Primary document | Mar 23, 2026 | Mar 18, 2026 |
| 3/A | Primary document | Mar 23, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 19, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 19, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 19, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 19, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 19, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 19, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 19, 2026 | Mar 18, 2026 |
Showing 26 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- AAPG (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Cayman Islands
- Headquarters
- Suzhou , Jiangsu
- SEC filer status
- Non-accelerated filer, Emerging growth company
- SEC CIK
- 2023311
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.